3 doses of Pfizer–BioNTech COVID vaccine better than 2
A Kaiser Permanente study published Feb. 14, 2022, in The Lancet Regional Health-Americas found that one month after a third dose, the Pfizer-BioNTech COVID-19 vaccine conferred higher effectiveness against infection and ...
Feb 14, 2022
0
7